oxazoles has been researched along with Nervous System Diseases in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Biggerstaff, A; Cerne, R; Cook, JM; Jin, X; Kivell, BM; Knutson, DE; Lippa, A; Mian, MY; Pandey, KP; Ping, X; Sharmin, D; Smith, JL; Witkin, JM | 1 |
| Muller, WJ | 1 |
| Aubin, N; Barneoud, P; Burnier, P; Caille, D; Carter, C; Charieras, T; Curet, O; Gardes, A; George, P; Jegham, S; Le Kim, A; Lolivier, J; Marc, C; Pandini, M; Perron, C; Puech, F; Scatton, B; Sontag, N | 1 |
| Allen, SD; Kinsolving, CR; Mitchell, JT; Mullen, GB; Ordy, MJ; Palmer, GC; Radov, LA; Simmons, RD; St Georgiev, V; Strand, JC | 1 |
| Shinozaki, H | 1 |
| Blessing, JA; Buchsbaum, HJ; DiSaia, PJ; McGuire, WP | 1 |
3 review(s) available for oxazoles and Nervous System Diseases
| Article | Year |
|---|---|
The imidazodiazepine, KRM-II-81: An example of a newly emerging generation of GABAkines for neurological and psychiatric disorders.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Antidepressive Agents; Anxiety; Epilepsy; GABA Agents; GABA-A Receptor Agonists; Humans; Mental Disorders; Nervous System Diseases; Neuralgia; Oxazoles; Receptors, GABA; Receptors, GABA-A; Seizures | 2022 |
Treatment of perinatal viral infections to improve neurologic outcomes.
Topics: Acyclovir; Antiviral Agents; Brain; Cognition; Cognition Disorders; Encephalitis, Herpes Simplex; Enterovirus Infections; Female; Ganciclovir; HIV Infections; Humans; Infant, Newborn; Nervous System Diseases; Oxadiazoles; Oxazoles; Pregnancy; Valganciclovir; Virus Diseases | 2017 |
Pharmacology of the glutamate receptor.
Topics: 2-Amino-5-phosphonovalerate; Amino Acids; Animals; Anticonvulsants; Antidepressive Agents; Azepines; Glutamates; Glutamic Acid; Membrane Potentials; Nervous System Diseases; Neurons; Oxazoles; Oxazolidinones; Piperidines; Receptors, Glutamate; Receptors, Neurotransmitter; Synapses | 1988 |
3 other study(ies) available for oxazoles and Nervous System Diseases
| Article | Year |
|---|---|
SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzophenones; Brain; Corpus Striatum; Disease Models, Animal; Dopamine; Drug Interactions; Levodopa; Maze Learning; Mice; Mice, Inbred C57BL; Monoamine Oxidase; Monoamine Oxidase Inhibitors; MPTP Poisoning; Nervous System Diseases; Nitrophenols; Oxazoles; Oxidopamine; Prefrontal Cortex; Quinolines; Rats; Rats, Sprague-Dawley; Serotonin; Stereotyped Behavior; Tolcapone; Tremor; Tyramine | 2004 |
Selection of orally active antifungal agents from 3,5-substituted isoxazolidine derivatives based on acute efficacy-safety profiles.
Topics: Administration, Oral; Analgesics; Animals; Anticonvulsants; Antifungal Agents; Female; Isoxazoles; Male; Mice; Microbial Sensitivity Tests; Nervous System Diseases; Oxazoles; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1989 |
Phase II trial of acivicin in patients with advanced epithelial ovarian carcinoma. A Gynecologic Oncology Group Study.
Topics: Adult; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Drug Evaluation; Female; Hematologic Diseases; Humans; Isoxazoles; Middle Aged; Nervous System Diseases; Ovarian Neoplasms; Oxazoles | 1986 |